You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大成生化科技(00809.HK)擬折價兩成向中民投配售17.8億股 籌資約2.4億港元
格隆匯 01-19 18:37

格隆匯1月19日丨大成生化科技(00809.HK)公佈,於2022年1月19日,公司擬向認購方睿烜(控股)投資(最終控股公司為中國民生投資股份有限公司)配售17.81億股新股份,佔經擴大後公司股份約16.7%。每股配售價為0.1345港元,較1月19日收市價折讓約19.9%。

認購事項的所得款項總額將約為2.396億港元。於扣除相關開支後,估計認購事項的所得款項淨額將約為2.395億港元。認購事項的所得款項淨額將主要用於局部恢復集團位於吉林省長春市興隆山廠區的生產營運。

公吿稱,於2021年11月30日,集團錄得現金及現金等值項目總額約5407.6萬港元及流動負債約115.51億港元。因此,集團正迫切需要現金及營運資金。此外,隨着中國玉米提煉產業復甦,透過訂立認購協議,集團可在較短時間內且無額外利息負擔的情況下,籌集資金撥付集團生產營運的局部復產,並同時進一步加強其財務狀況。

此外,公司已向聯交所申請於2022年1月20日上午九時正起恢復股份買賣。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account